chr8-74361906-T-G

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_018972.4(GDAP1):ā€‹c.507T>Gā€‹(p.Ser169Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.305 in 1,593,766 control chromosomes in the GnomAD database, including 78,134 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.26 ( 5924 hom., cov: 33)
Exomes š‘“: 0.31 ( 72210 hom. )

Consequence

GDAP1
NM_018972.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:2B:10

Conservation

PhyloP100: -0.915
Variant links:
Genes affected
GDAP1 (HGNC:15968): (ganglioside induced differentiation associated protein 1) This gene encodes a member of the ganglioside-induced differentiation-associated protein family, which may play a role in a signal transduction pathway during neuronal development. Mutations in this gene have been associated with various forms of Charcot-Marie-Tooth Disease and neuropathy. Two transcript variants encoding different isoforms and a noncoding variant have been identified for this gene. [provided by RefSeq, Feb 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 8-74361906-T-G is Benign according to our data. Variant chr8-74361906-T-G is described in ClinVar as [Benign]. Clinvar id is 261065.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-74361906-T-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.915 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.332 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
GDAP1NM_018972.4 linkuse as main transcriptc.507T>G p.Ser169Ser synonymous_variant 4/6 ENST00000220822.12 NP_061845.2 Q8TB36-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
GDAP1ENST00000220822.12 linkuse as main transcriptc.507T>G p.Ser169Ser synonymous_variant 4/61 NM_018972.4 ENSP00000220822.7 Q8TB36-1

Frequencies

GnomAD3 genomes
AF:
0.260
AC:
39562
AN:
152060
Hom.:
5924
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.118
Gnomad AMI
AF:
0.314
Gnomad AMR
AF:
0.241
Gnomad ASJ
AF:
0.307
Gnomad EAS
AF:
0.312
Gnomad SAS
AF:
0.210
Gnomad FIN
AF:
0.333
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.336
Gnomad OTH
AF:
0.279
GnomAD3 exomes
AF:
0.279
AC:
70092
AN:
251004
Hom.:
10687
AF XY:
0.283
AC XY:
38405
AN XY:
135726
show subpopulations
Gnomad AFR exome
AF:
0.114
Gnomad AMR exome
AF:
0.185
Gnomad ASJ exome
AF:
0.283
Gnomad EAS exome
AF:
0.323
Gnomad SAS exome
AF:
0.209
Gnomad FIN exome
AF:
0.328
Gnomad NFE exome
AF:
0.332
Gnomad OTH exome
AF:
0.306
GnomAD4 exome
AF:
0.309
AC:
446116
AN:
1441588
Hom.:
72210
Cov.:
29
AF XY:
0.307
AC XY:
220652
AN XY:
718540
show subpopulations
Gnomad4 AFR exome
AF:
0.107
Gnomad4 AMR exome
AF:
0.194
Gnomad4 ASJ exome
AF:
0.287
Gnomad4 EAS exome
AF:
0.278
Gnomad4 SAS exome
AF:
0.208
Gnomad4 FIN exome
AF:
0.332
Gnomad4 NFE exome
AF:
0.330
Gnomad4 OTH exome
AF:
0.294
GnomAD4 genome
AF:
0.260
AC:
39579
AN:
152178
Hom.:
5924
Cov.:
33
AF XY:
0.260
AC XY:
19375
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.117
Gnomad4 AMR
AF:
0.241
Gnomad4 ASJ
AF:
0.307
Gnomad4 EAS
AF:
0.313
Gnomad4 SAS
AF:
0.210
Gnomad4 FIN
AF:
0.333
Gnomad4 NFE
AF:
0.336
Gnomad4 OTH
AF:
0.281
Alfa
AF:
0.284
Hom.:
3869
Bravo
AF:
0.246
Asia WGS
AF:
0.256
AC:
892
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:2Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:4
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 22, 2021- -
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium-- -
not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxMar 03, 2015- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Charcot-Marie-Tooth disease axonal type 2K Uncertain:1
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium Ii, University Of MiamiJan 06, 2016- -
Charcot-Marie-Tooth disease Benign:1
Benign, criteria provided, single submitterclinical testingMolecular Genetics Laboratory, London Health Sciences Centre-- -
Charcot-Marie-Tooth disease recessive intermediate A Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Charcot-Marie-Tooth disease type 4A Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Charcot-Marie-Tooth disease, axonal, with vocal cord paresis, autosomal recessive Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
5.4
DANN
Benign
0.76

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11554166; hg19: chr8-75274141; COSMIC: COSV55184803; COSMIC: COSV55184803; API